New patent expiration for Bristol Myers drug SPRYCEL

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for SPRYCEL
Annual Drug Patent Expirations for SPRYCEL

Sprycel is a drug marketed by Bristol Myers Squibb and is included in one NDA. It is available from one supplier. There are five patents protecting this drug and three Paragraph IV challenges.

SPRYCEL drug price trends.

Drug patent litigation for SPRYCEL.

The generic ingredient in SPRYCEL is dasatinib. One supplier is listed for this compound. Additional details are available on the dasatinib profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top